Centessa shareholders approve all proposals at 2025 AGM, including director re-elections

Centessa Pharmaceuticals plc

Re-elected Arjun Goyal with 116.9M votes for, 463,793 against; Samarth Kulkarni with 97.7M for, 19.6M against.
Approved KPMG LLP as UK statutory auditors and KPMG LLP (Delaware) as independent auditor for FY2025.
Adopted UK statutory accounts for FY2024; no dividend recommended.
Authorized directors to allot shares up to £133,184 nominal value under Companies Act.
Special resolution passed to empower board to allot equity for cash without pre-emption rights.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.